arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Adia Nutrition, Inc.

ADIA
Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
5 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Moderately Bearish
auto_awesome

Analytical Summary

Adia Nutrition, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap
Dividend Yield
Revenue Growth 145.6%
Op. Margin -86.2%
ROIC 36.2%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

5-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$176.28K
↑ +145.6%
Net Income Profit after all expenses
$-162.53K
↓ -39.8%
Operating Margin Operating profit as % of sales
-86.2%
↑ +44.1% 5th
FCF / Share Free cash flow per share
$-0.00
↓ -97.2%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
100
Cash Quality
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 3 years · 5 quarters